290 related articles for article (PubMed ID: 28781887)
1. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance.
Woods NT; Baskin R; Golubeva V; Jhuraney A; De-Gregoriis G; Vaclova T; Goldgar DE; Couch FJ; Carvalho MA; Iversen ES; Monteiro AN
NPJ Genom Med; 2016; 1():16001-. PubMed ID: 28781887
[TBL] [Abstract][Full Text] [Related]
2. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
Fernandes VC; Golubeva VA; Di Pietro G; Shields C; Amankwah K; Nepomuceno TC; de Gregoriis G; Abreu RBV; Harro C; Gomes TT; Silva RF; Suarez-Kurtz G; Couch FJ; Iversen ES; Monteiro ANA; Carvalho MA
J Biol Chem; 2019 Apr; 294(15):5980-5992. PubMed ID: 30765603
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
Guidugli L; Shimelis H; Masica DL; Pankratz VS; Lipton GB; Singh N; Hu C; Monteiro ANA; Lindor NM; Goldgar DE; Karchin R; Iversen ES; Couch FJ
Am J Hum Genet; 2018 Feb; 102(2):233-248. PubMed ID: 29394989
[TBL] [Abstract][Full Text] [Related]
4. Classification of VUS and unclassified variants in
Sinha S; Wang SM
Comput Struct Biotechnol J; 2020; 18():723-736. PubMed ID: 32257056
[TBL] [Abstract][Full Text] [Related]
5. Germline Missense Variants in
Golubeva VA; Nepomuceno TC; Monteiro ANA
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013702
[TBL] [Abstract][Full Text] [Related]
6. Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight
Caleca L; Radice P
Front Oncol; 2023; 13():1146604. PubMed ID: 37168384
[TBL] [Abstract][Full Text] [Related]
7. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of
Petitalot A; Dardillac E; Jacquet E; Nhiri N; Guirouilh-Barbat J; Julien P; Bouazzaoui I; Bonte D; Feunteun J; Schnell JA; Lafitte P; Aude JC; Noguès C; Rouleau E; Lidereau R; Lopez BS; Zinn-Justin S; Caputo SM;
Mol Cancer Res; 2019 Jan; 17(1):54-69. PubMed ID: 30257991
[No Abstract] [Full Text] [Related]
8. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance.
Iversen ES; Lipton G; Hart SN; Lee KY; Hu C; Polley EC; Pesaran T; Yussuf A; LaDuca H; Chao E; Karam R; Goldgar DE; Couch FJ; Monteiro ANA
NPJ Genom Med; 2022 Jun; 7(1):35. PubMed ID: 35665744
[TBL] [Abstract][Full Text] [Related]
9. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA
Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888
[TBL] [Abstract][Full Text] [Related]
10. GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.
Caleca L; Colombo M; van Overeem Hansen T; Lázaro C; Manoukian S; Parsons MT; Spurdle AB; Radice P
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30696104
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 Circos: a visualisation resource for functional analysis of missense variants.
Jhuraney A; Velkova A; Johnson RC; Kessing B; Carvalho RS; Whiley P; Spurdle AB; Vreeswijk MP; Caputo SM; Millot GA; Vega A; Coquelle N; Galli A; Eccles D; Blok MJ; Pal T; van der Luijt RB; Santamariña Pena M; Neuhausen SL; Donenberg T; Machackova E; Thomas S; Vallée M; Couch FJ; Tavtigian SV; Glover JN; Carvalho MA; Brody LC; Sharan SK; Monteiro AN;
J Med Genet; 2015 Apr; 52(4):224-30. PubMed ID: 25643705
[TBL] [Abstract][Full Text] [Related]
12. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
Toland AE; Andreassen PR
J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
[TBL] [Abstract][Full Text] [Related]
13. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays.
Biswas K; Lipton GB; Stauffer S; Sullivan T; Cleveland L; Southon E; Reid S; Magidson V; Iversen ES; Sharan SK
NPJ Genom Med; 2020 Dec; 5(1):52. PubMed ID: 33293522
[TBL] [Abstract][Full Text] [Related]
14. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.
Iversen ES; Couch FJ; Goldgar DE; Tavtigian SV; Monteiro AN
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1078-88. PubMed ID: 21447777
[TBL] [Abstract][Full Text] [Related]
15. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
[TBL] [Abstract][Full Text] [Related]
16. Reclassification of
Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
[TBL] [Abstract][Full Text] [Related]
17. DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus.
Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
bioRxiv; 2023 Apr; ():. PubMed ID: 37090572
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
[TBL] [Abstract][Full Text] [Related]
20. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]